Navigation Links
Mediterranean Diet May Boost Alzheimer's Survival
Date:9/10/2007

Patients eating most greens, grains, olive oil lived 4 years longer, study found

MONDAY, Sept. 10 (HealthDay News) -- Consuming what's known as a Mediterranean diet -- one loaded with fruits, vegetables, grains and olive oil -- may help Alzheimer's patients live longer, a new study suggests.

The observation comes after researchers tracked the dietary habits of people diagnosed with early-stage Alzheimer's. It follows on earlier work by the same team that suggests these diets may lower the risk of developing Alzheimer's in the first place.

"This time, we found that Alzheimer's patients who were following the Mediterranean diet had longer survival as compared to those who were following the diet less," said study lead author Dr. Nikolaos Scarmeas, an assistant professor in the department of neurology at Columbia University Medical Center in New York City.

The study is published in the Sept. 11 issue of Neurology.

According to the American Heart Association, diets native to the 16 countries bordering the Mediterranean Sea varies somewhat region to region. However, most regimens include a high intake of fruits, vegetables, breads, cereals, potatoes, beans, nuts, seeds, and olive oil. More than half of all fat-sourced calories in the Mediterranean diet come from monounsaturated fats, such as olive oil. Dairy, fish, poultry, and other sources of saturated fats are eaten at low to moderate levels, the AHA say.

Heart disease rates in Mediterranean nations are lower than in the United States, the AHA adds, although it's not clear that diet alone is responsible for the difference.

To further examine the potential health benefits of the Mediterranean diet, Scarmeas' team compared nutrition and disease progression between 1992 and 2002 among 192 patients with early-stage Alzheimer's, all of whom lived in New York City.

All the patients were 65 and older, most were non-white, and
'/>"/>

Copyright©2007 ScoutNews,LLC.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Mediterranean diet aids Asian masses
2. The Mediterranean magic: helpful in heart disease
3. Mediterranean Diet Lowers Inflammation Levels In Elderly
4. Risk Of Dementia May Be Reduced By Mediterranean Diet
5. Mediterranean Diet Effective in Staving off Risk of Alzheimer’
6. Mediterranean Diet And Exercise, Key To Good Health
7. Mediterranean Diet And Exercise Increases Life Expectancy
8. Alzheimer’s Risk Lowered with Mediterranean Die
9. Mediterranean Diet Could Help to Prevent COPD
10. Present Rate of Carbon Emissions Could Increase Number of Hot Days in Mediterranean by 500 Pc
11. Spirulina may be the next immune boost on the block
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine Technology:Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 2Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 3Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 4Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 5Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 6Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 7Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 8Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 9Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 10AdvanDx Receives FDA 510(k) Clearance for 90 Minutes PNA FISH(R) Protocol for Identifying Staphylococcal Bloodstream Pathogens 2AdvanDx Receives FDA 510(k) Clearance for 90 Minutes PNA FISH(R) Protocol for Identifying Staphylococcal Bloodstream Pathogens 3China-Biotics, Inc. to Hold 2009 Annual Meeting of Stockholders on March 5, 2010 2China-Biotics, Inc. to Hold 2009 Annual Meeting of Stockholders on March 5, 2010 3Trius Therapeutics Files Registration Statement for Proposed Initial Public Offering 6063 1Society of Interventional Radiology hosts oncology therapies Webinar offers resources 10650 1Society of Interventional Radiology hosts oncology therapies Webinar offers resources 10650 2Singing in Pregnancy May Be Harder Work 60872 1